Clinical response in relapsed/refractory AML patients correlates with leukemic blast mobilization and differentiation induced by BL-8040, a potent CXCR4 antagonist; Results of a phase IIA study Meeting Abstract
| Authors: | Borthakur, G.; Tallman, M. S.; Ofran, Y.; Foran, J.; Uy, G. L.; DiPersio, J. F.; Nagler, A.; Rowe, J. M.; Showel, M. M.; Altman, J. K.; Peled, A.; Abraham, M.; Pereg, Y.; Vainstein, A.; Oberkovitz, G.; Aharon, A.; Bueso-Ramos, C.; Cortes, J. E.; Andreeff, M. |
| Abstract Title: | Clinical response in relapsed/refractory AML patients correlates with leukemic blast mobilization and differentiation induced by BL-8040, a potent CXCR4 antagonist; Results of a phase IIA study |
| Meeting Title: | 21st Congress of the European Hematology Association (EHA) |
| Journal Title: | Haematologica |
| Volume: | 101 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2016 Jun 9-12 |
| Meeting Location: | Copenhagen, Denmark |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2016-06-01 |
| Start Page: | 43 |
| Language: | English |
| ACCESSION: | WOS:000379484600093 |
| PROVIDER: | wos |
| PMCID: | PMC4894295 |
| Notes: | Meeting Abstract: P190 -- Source: Wos |
MSK Authors
-
649Tallman